HRT Financial’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.27M | Buy |
371,013
+177,730
| +92% | +$609K | 0.01% | 952 |
|
|
2025
Q1 | $431K | Sell |
193,283
-56,943
| -23% | -$127K | ﹤0.01% | 1359 |
|
|
2024
Q4 | $733K | Buy |
250,226
+120,322
| +93% | +$352K | ﹤0.01% | 1091 |
|
|
2024
Q3 | $337K | Buy |
+129,904
| New | +$337K | ﹤0.01% | 1616 |
|
|
2024
Q1 | – | Sell |
-90,562
| Closed | -$517K | – | 2084 |
|
|
2023
Q4 | $517K | Buy |
90,562
+28,361
| +46% | +$162K | ﹤0.01% | 1236 |
|
|
2023
Q3 | $286K | Sell |
62,201
-67,011
| -52% | -$308K | ﹤0.01% | 1492 |
|
|
2023
Q2 | $834K | Sell |
129,212
-427,062
| -77% | -$2.76M | 0.01% | 973 |
|
|
2023
Q1 | $4.19M | Buy |
+556,274
| New | +$4.19M | 0.05% | 288 |
|
|
2022
Q2 | – | Sell |
-62,568
| Closed | -$610K | – | 2755 |
|
|
2022
Q1 | $610K | Buy |
+62,568
| New | +$610K | ﹤0.01% | 1337 |
|
|
2021
Q2 | – | Sell |
-27,366
| Closed | -$929K | – | 2659 |
|
|
2021
Q1 | $929K | Buy |
+27,366
| New | +$929K | 0.01% | 1096 |
|